ストックスクリーナーアプリを入手
248.38
2.91%
-7.45
前日終値:
$255.83
開ける：
$244.16
24時間の取引高:
1.30M
Relative Volume:
1.21
時価総額：
$36.25B
収益：
$5.26B
当期純損益:
$1.44B
株価収益率:
25.42
EPS:
9.7713
ネットキャッシュフロー:
$1.76B
1週間 パフォーマンス:
-0.85%
1か月 パフォーマンス:
+0.61%
6か月 パフォーマンス:
+1.47%
1年 パフォーマンス:
-0.26%
1日の値動き範囲:
$237.62
$253.88
1週間の範囲:
$237.62
$258.09
52週間の値動き範囲:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
RMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
248.38 | 37.34B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
ISRG
Intuitive Surgical Inc
|
567.37 | 203.30B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
191.82 | 55.38B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.20 | 38.96B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
WST
West Pharmaceutical Services Inc
|
274.14 | 19.95B | 2.96B | 487.70M | 344.00M | 6.6758 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-18 | 開始されました | Citigroup | Buy |
| 2025-09-02 | アップグレード | CLSA | Hold → Outperform |
| 2025-07-15 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2025-01-16 | 開始されました | Goldman | Buy |
| 2025-01-10 | 開始されました | Piper Sandler | Neutral |
| 2024-12-13 | 開始されました | Stifel | Hold |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-09-18 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | ダウングレード | Needham | Buy → Hold |
| 2024-06-25 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | アップグレード | Needham | Hold → Buy |
| 2023-09-05 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 開始されました | UBS | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
| 2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
| 2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-31 | アップグレード | Goldman | Neutral → Buy |
| 2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-01-13 | アップグレード | CLSA | Outperform → Buy |
| 2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
| 2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
| 2021-08-02 | ダウングレード | Needham | Buy → Hold |
| 2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
| 2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
| 2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-06-22 | 開始されました | Robert W. Baird | Neutral |
| 2021-06-21 | 繰り返されました | Needham | Buy |
| 2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-09 | アップグレード | CLSA | Sell → Outperform |
| 2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-03-16 | アップグレード | Needham | Hold → Buy |
| 2020-11-02 | アップグレード | UBS | Neutral → Buy |
| 2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 開始されました | CLSA | Underperform |
| 2020-01-31 | ダウングレード | UBS | Buy → Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Perform |
| 2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | アップグレード | UBS | Neutral → Buy |
| 2019-07-16 | ダウングレード | UBS | Buy → Neutral |
| 2019-05-06 | アップグレード | UBS | Neutral → Buy |
| 2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
Is ResMed Inc. stock positioned for digital growth eraBond Market & Weekly Chart Analysis and Trade Guides - Newser
What makes ResMed Inc. stock appealing to growth investorsMarket Activity Report & Free Daily Entry Point Trade Alerts - Newser
Why ResMed Inc. stock benefits from AI revolution2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser
Does ResMed Inc. stock trade below intrinsic valueTrade Volume Report & Real-Time Stock Price Movement Reports - Newser
Resmed Inc Officer Plans Sale of Common Stock - TipRanks
Mackenzie Financial Corp Sells 7,569 Shares of ResMed Inc. $RMD - MarketBeat
ResMed (RMD) Dropped from Goldman Sachs' APAC Conviction List - GuruFocus
Hsbc Holdings PLC Boosts Stake in ResMed Inc. $RMD - MarketBeat
State Board of Administration of Florida Retirement System Boosts Stock Position in ResMed Inc. $RMD - MarketBeat
Korea Investment CORP Has $21.40 Million Holdings in ResMed Inc. $RMD - MarketBeat
Russell Investments Group Ltd. Buys 8,601 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Holdings Lifted by Groupama Asset Managment - MarketBeat
Capital Fund Management S.A. Sells 1,310 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc (NYSE:RMD) S&P 500 Index Cloud-Based Respiratory Care - Kalkine Media
Neuberger Berman Group LLC Purchases 22,431 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Stock Holdings Trimmed by Skandinaviska Enskilda Banken AB publ - MarketBeat
Bond Watch: Can ResMed Inc. stock double in next 5 yearsWeekly Gains Summary & Intraday High Probability Setup Alerts - BỘ NỘI VỤ
BLI Banque de Luxembourg Investments Has $73.95 Million Stock Position in ResMed Inc. $RMD - MarketBeat
American Century Companies Inc. Has $45.38 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc Reports Changes in Beneficial Ownership - MSN
Calculating The Intrinsic Value Of ResMed Inc. (NYSE:RMD) - Yahoo Finance
Northwest & Ethical Investments L.P. Decreases Position in ResMed Inc. $RMD - MarketBeat
Jefferies Financial Group Inc. Trims Holdings in ResMed Inc. $RMD - MarketBeat
Employees Retirement System of Texas Purchases Shares of 22,300 ResMed Inc. $RMD - MarketBeat
Why ResMed Inc. stock is a value investor pick2025 Market WrapUp & AI Driven Stock Movement Reports - BỘ NỘI VỤ
ResMed (NYSE:RMD) Director Sells $524,025.00 in Stock - MarketBeat
Michael J Farrell Makes Strategic Play: Invests $179K In ResMed Stock Options - Benzinga
ResMed Inc. Reports Changes in Beneficial Ownership - MSN
ResMed Inc. $RMD Shares Acquired by North Star Asset Management Inc. - MarketBeat
Prudential Financial Inc. Has $24.07 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
Franklin Resources Inc. Decreases Stake in ResMed Inc. $RMD - MarketBeat
Charles Schwab Investment Management Inc. Purchases 22,873 Shares of ResMed Inc. $RMD - MarketBeat
Insider Sell: Witte De Sells 2,055 Shares of ResMed Inc (RMD) - GuruFocus
Resmed director De Witte sells $524k in stock By Investing.com - Investing.com India
Resmed director De Witte sells $524k in stock - Investing.com
ResMed Director Increases Stake with New Stock Acquisition - MSN
ResMed Inc. Announces Changes in Executive Stock Ownership - MSN
ResMed Inc. Director Acquires Additional Shares Through RSUs - MSN
ResMed Director Acquires Additional Shares Through RSUs - The Globe and Mail
Resmed Inc Director Plans Sale of Common Stock - TipRanks
Evaluating ResMed (RMD): Is There Hidden Value After a Week of Quiet Trading? - simplywall.st
ResMed Bets Big On Sleep Tech, But Risks Are Growing - Finimize
Aviso Financial Inc. Buys 9,147 Shares of ResMed Inc. $RMD - MarketBeat
Resmed’s Q1 Earnings Delivered Modest Growth And Raised Optimism - Finimize
ResMed Inc. Announces Change in Board Leadership - TipRanks
ResMed Director Acquires Additional Shares in Strategic Move - TipRanks
ResMed Inc Director Acquires Additional Shares, Signaling Confidence - TipRanks
ResMed Inc. Expands Equity Incentive Plan with Additional Share Registration - MSN
IDEXX Laboratories Vs ResMed: Which Stock Could Rally? - Forbes
ResMed Inc. Expands Employee Stock Purchase Plan with New Share Registration - MSN
Swiss National Bank Boosts Position in ResMed Inc. $RMD - MarketBeat
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):